Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences

C. MATHEÏ; G. ROBAEYS; P. VAN DAMME; F. BUNTINX; R. VERRANDO

doi:10.1017/S0950268804002973

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The prevalence of hepatitis C and related risk factors in drug users were compared in two geographic regions in Belgium, the city of Antwerp and the mixed urban–rural area of Limburg. All 310 participants were surveyed and screened for hepatitis B, hepatitis C and HIV. Prevalence rates of anti-HCV, anti-HBc and anti-HIV were 71, 62 and 4% in Antwerp and 46, 21 and 0% in Limburg respectively. Injecting drug use, duration of injecting drug use, work as a commercial sex-worker, originating from Turkey or Northern Africa, marginalization and anti-HBc positivity were identified as independent predictors for hepatitis C infection. In this study an important difference in HCV seroprevalence among drug users in a methadone maintenance programme across two geographic regions in Belgium was demonstrated. This was explained not only by variations in drug-related risk behaviour, but also by differences in sexual risk behaviour and socio-economic status.

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Matheï, C. Wollants, E. Verbeeck, J. Van Ranst, M. Robaeys, G. Van Damme, P. and Buntinx, F. 2005. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. European Journal of Clinical Microbiology & Infectious Diseases, Vol. 24, Issue. 8, p. 514.

Reimer, Jens Backmund, Markus and Haasen, Christian 2005. New psychiatric and psychological aspects of diagnosis and treatment of hepatitis C and relevance for opiate dependence. Current Opinion in Psychiatry, Vol. 18, Issue. 6, p. 678.

Mathei, C. Shkedy, Z. Denis, B. Kabali, C. Aerts, M. Molenberghs, G. Van Damme, P. and Buntinx, F. 2006. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Journal of Viral Hepatitis, Vol. 13, Issue. 8, p. 560.

Reimer, Jens Lorenzen, Juergen Baetz, Bernhard Fischer, Benedikt Rehm, Juergen Haasen, Christian and Backmund, Markus 2007. Multiple viral hepatitis in injection drug users and associated risk factors. Journal of Gastroenterology and Hepatology, Vol. 22, Issue. 1, p. 80.

Scheinmann, Roberta Hagan, Holly Lelutiu-Weinberger, Corina Stern, Rebecca Jarlais, Don C. Des Flom, Peter L. and Strauss, Shiela 2007. Non-injection drug use and Hepatitis C Virus: A systematic review. Drug and Alcohol Dependence, Vol. 89, Issue. 1, p. 1.

Hagan, Holly Des Jarlais, Don C. Stern, Rebecca Lelutiu-Weinberger, Corina Scheinmann, Roberta Strauss, Shiela and Flom, Peter L. 2007. HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, Vol. 18, Issue. 5, p. 341.

Hagan, H. Pouget, E. R. Des Jarlais, D. C. and Lelutiu-Weinberger, C. 2008. Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place. American Journal of Epidemiology, Vol. 168, Issue. 10, p. 1099.

Matheï, C. Van Dooren, S. Lemey, P. Van Damme, P. Buntinx, F. and Vandamme, A.‐M. 2008. The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium. Journal of Viral Hepatitis, Vol. 15, Issue. 6, p. 399.

Robaeys, G. Nevens, F. Stärkel, P. Colle, I. Van Eyken, P. Bruckers, L. Van Ranst, M. and Buntinx, F. 2009. Previous Intravenous Substance Use and Outcome of Liver Transplantation in Patients With Chronic Hepatitis C Infection. Transplantation Proceedings, Vol. 41, Issue. 2, p. 589.

Wheeler, David C. Hickson, DeMarc A. and Waller, Lance A. 2010. Assessing local model adequacy in Bayesian hierarchical models using the partitioned deviance information criterion. Computational Statistics & Data Analysis, Vol. 54, Issue. 6, p. 1657.

Poddar, Nirmala Lenka, Priya Ranjan Chayani, Nirupama Mohanty,, Sunil Mallick, Bandana and Pattnaik, Dipti 2012. SEROPREVALENCE OF HEPATITIS-C VIRUS IN BLOOD DONORS AND HIGH RISK INDIVIDUALS. Journal of Evolution of Medical and Dental Sciences, Vol. 1, Issue. 6, p. 959.

Palmateer, Norah E. Hutchinson, Sharon J. Innes, Hamish Schnier, Christian Wu, Olivia Goldberg, David J. and Hickman, Matthew 2013. Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. International Journal of Drug Policy, Vol. 24, Issue. 2, p. 85.

Vilibic-Cavlek, Tatjana 2015. Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology, Vol. 21, Issue. 32, p. 9476.

Mwangi, Joseph Nganga, Zipporah Mpoke, Solomon Lihana, Raphael Kinyua, Joyceline Lagat, Nancy Muriuki, Joseph Lel, Rency Kageha, Sheila Osman, Saida and Ichimura, Hiroshi 2016. Hepatitis C virus genotypes in Kenya. Archives of Virology, Vol. 161, Issue. 1, p. 95.

Bielen, Rob Moreno, Christophe Van Vlierberghe, Hans Bourgeois, Stefan Mulkay, Jean-Pierre Vanwolleghem, Thomas Verlinden, Wim Brixko, Christian Decaestecker, Jochen De Galocsy, Chantal Janssens, Filip Cool, Mike Van Overbeke, Lode Van Steenkiste, Christophe D'heygere, François Cools, Wilfried Nevens, Frederik and Robaeys, Geert 2017. Belgian experience with direct acting antivirals in people who inject drugs. Drug and Alcohol Dependence, Vol. 177, Issue. , p. 214.

Kracht, Patricia A. M. de Gee, Elisabeth A. van der Poel, Agnes Verhagen, Marc A. M. T. Hoepelman, Andy I. M. Croes, Esther A. and Arends, Joop E. 2019. Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study. Harm Reduction Journal, Vol. 16, Issue. 1,

Busschots, Dana Kremer, Cécile Bielen, Rob Koc, Özgür Muhammet Heyens, Leen Dercon, Eefje Verrando, Rita Windelinckx, Tessa Maertens, Griet Bourgeois, Stefan Hens, Niel Matheï, Catharina and Robaeys, Geert 2021. Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium. Harm Reduction Journal, Vol. 18, Issue. 1,

Busschots, D Arain, A Bielen, R Koc, Ö.M. Bruckers, L Rakhmawati, T Corten, K Lebbe, C Cornelis, K Mathei, C Buntinx, F Hens, N and Robaeys, G 2021. Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in Belgium. Acta Gastro Enterologica Belgica, Vol. 84, Issue. 2, p. 311.

Robaeys, Geert and Bielen, Rob 2021. Hepatitis C: Care and Treatment. p. 191.

Article contents

Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences

Abstract

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests